![](https://ml.globenewswire.com/media/8eb8effc-49a5-4b24-911f-d3e6dfa9c8a9/medium/gomekli-mirdametinib-capsules-and-tablets-for-oral-suspensio.jpg)
UPDATE: SpringWorks Therapeutics Announces FDA Approval of GOMEKLI™ (mirdametinib) for the Treatment of Adult and ...
– GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN – – Approval based on positive data from Phase 2b ReNeu trial, which showed GOMEKLI treatment resulted in robust ORR, deep and durable reductions in tumor volume, …